Viewing Study NCT02702908


Ignite Creation Date: 2025-12-26 @ 10:56 AM
Ignite Modification Date: 2026-04-19 @ 10:00 PM
Study NCT ID: NCT02702908
Status: COMPLETED
Last Update Posted: 2018-01-19
First Post: 2016-03-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Second Primary Cancers in Patients With Castration Resistant Prostate Cancer
Sponsor: Bayer
Organization:

Study Overview

Official Title: Second Primary Cancers in Patients With Castration Resistant Prostate Cancer (BOCARP)
Status: COMPLETED
Status Verified Date: 2018-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: BOCARP
Brief Summary: This study aims at estimating the incidence of second primary malignancies as well as the overall survival among metastasized prostate cancer (mPC) and metastasized castrate-resistant prostate cancer (mCRPC) patients not treated with radium-223-dichloride.
Detailed Description: This study aims at estimating the incidence of second primary malignancies as well as the overall survival among mPC and mCRPC patients not treated with radium-223-dichloride. The source of data for this study will be the German Pharmacoepidemiological Research Database (GePaRD). A retrospective cohort study covering the time period from 2004 to 2013 will be conducted. The study population will comprise CRPC patients developing bone metastases. These patients will be followed up for the occurrence of second primary malignancies, end of study, or death due to any cause. As this study serves as a historical control group for a single-arm observational study, incidence rates of second primary malignancies obtained from these studies will be compared by the standardized incidence ratio using results from this study as a reference.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
EUPAS12665 REGISTRY ENCEPP View